Dennis Moore in Maywood, Illinois

Home Illinois Maywood

Dennis Moore has Otolaryngology as his primary medical specialty. Their primary office is: 2160 S 1st Ave in Maywood, Illinois.

They're a part of the: Loyola University Medical Center medical group which has around 877 members. You can call their office at 708-216-9000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Loyola University Of Chicago, Stritch School Of Medicine and graduated in 1982 (around 42 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Dennis M Moore Office Phone and Directions

Dennis Moore
Loyola University Medical Center
2160 S 1st Ave
Maywood, Illinois 60153
708-216-9000

Patient Ratings
Please rate your experience with Dennis Moore below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 708-216-9000

Enter a starting address:

Healthcare Info for Dennis Moore

Medical School: Loyola University Of Chicago, Stritch School Of Medicine
Graduation Year: 1982
The Primary Medical Specialty for Dennis Moore is listed as: Otolaryngology
Approximate Years of Experience: 42
PAC (PECOS ID)#: 9830289933
NPI #: 1295832483
NPI Created On: 09/20/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207YX0901X
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Diagnostic examination of voice box using flexible endoscope
Removal of impact ear wax, one ear
Removal of impact ear wax, one ear
Diagnostic examination of ear and nose
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788088345

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788088347

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788088349

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788088351

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: ERLEADA

Associated Drug #2: 59676-600-12

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RYBREVANT

Name Of Drug #3: 57894-501-01

Payments Total: $84

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Food expense associated with business interaction

Record ID:: 807485241

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Implantable hearing solution

Name of Drug #1: Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode

Drug or Biological: Device

Product Category #2: Implantable hearing solution

Name Of Drug #2:: Baha BI300 implant 4 mm

Drug or Biological #3:: Device

Product Category #3: Implantable hearing solution

Name of Drug: Cochlear Osia OSI200 Implant